These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 10762161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
    De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ.
    Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012
    [Abstract] [Full Text] [Related]

  • 4. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
    Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, Ravert HT, Dannals RF.
    Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
    [Abstract] [Full Text] [Related]

  • 5. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
    Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE.
    Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
    [Abstract] [Full Text] [Related]

  • 6. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
    Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M.
    Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
    [Abstract] [Full Text] [Related]

  • 7. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
    Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, McKenzie J, McCormick S, Ruth TJ, Sossi V, de la Fuente-Fernandez R, Stoessl AJ.
    Brain; 2011 Nov; 134(Pt 11):3290-8. PubMed ID: 22075521
    [Abstract] [Full Text] [Related]

  • 9. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T, Condé F, Grégoire MC, Frouin V, Coulon C, Fuseau C, Hinnen F, Dollé F, Hantraye P, Bottlaender M.
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of dopaminergic activity in early Parkinson's disease.
    Tedroff J, Ekesbo A, Rydin E, Långström B, Hagberg G.
    Ann Neurol; 1999 Sep; 46(3):359-65. PubMed ID: 10482266
    [Abstract] [Full Text] [Related]

  • 13. Age and severity of nigrostriatal damage at onset of Parkinson's disease.
    De La Fuente-Fernández R, Lim AS, Sossi V, Adam MJ, Ruth TJ, Calne DB, Stoessl AJ, Lee CS.
    Synapse; 2003 Feb; 47(2):152-8. PubMed ID: 12454953
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.
    Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA.
    Neurology; 2009 Apr 21; 72(16):1390-6. PubMed ID: 19380698
    [Abstract] [Full Text] [Related]

  • 16. [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.
    Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, Houle S.
    Neurology; 1997 Jun 21; 48(6):1578-83. PubMed ID: 9191769
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
    Gatley SJ, Volkow ND, Fowler JS, Dewey SL, Logan J.
    Synapse; 1995 Jun 21; 20(2):137-44. PubMed ID: 7570343
    [Abstract] [Full Text] [Related]

  • 18. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA.
    Neuropsychopharmacology; 2000 Dec 21; 23(6):667-75. PubMed ID: 11063922
    [Abstract] [Full Text] [Related]

  • 19. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Martin WR, Wieler M, Stoessl AJ, Schulzer M.
    Ann Neurol; 2008 Mar 21; 63(3):388-94. PubMed ID: 18240153
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.